May 17, 2023 / 11:00AM GMT
Rachel Curtis Gravesen - Curtis Consult - IR
Hello and welcome. Thanks for joining us for today's call to discuss Redx's interim results for the period ended March 31, 2023. I'm Rachel Curtis Gravesen. And in a moment, Redx's Chief Executive Officer, Lisa Anson; Chief Financial Officer, Pete Collum; and Chief Scientific Officer, Richard Armer; and Dr. Jane Robertson, the company's Chief Medical Officer, will present the progress made during this time by the company.
(Event Instructions)
But now, could we please move to the next slide? Because importantly, before we begin the actual presentation, I'd like to draw your attention to the disclaimer slide we have here on slide 2 and remind you that any statements made during this call that are not historical statements will be forward-looking statements. And as such, that means they'll be subject to risks and uncertainties, which, if they should materialize, could materially affect Redx's share price.
With that, I'd like to hand the call over to Redx's CEO, Lisa Anson, so she can begin the presentation.
Lisa Anson<
Half Year 2023 Redx Pharma PLC Earnings Call Transcript
Mar 27, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers